ARVO Meeting Abstracts
 QUICK SEARCH:   [advanced]


This Article
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Subramaniam, C. D.
Right arrow Articles by Costakos, D.
Right arrow Search for Related Content
Right arrow Articles by Subramaniam, C. D.
Right arrow Articles by Costakos, D.
Invest Ophthalmol Vis Sci 2012;53: E-Abstract 2084.
© 2012 ARVO


Assessing Macular Findings in Infants Screened for Retinopathy of Prematurity with Spectral Domain-Optical Coherence Tomography

C. Devika Subramaniam1A, Adam M. Dubis1B, Pooja Godara1A, Debra Felzer2, Cathy Brault2, Joseph Carroll1C and Deborah Costakos1A

AOphthalmology, BCell Biology, Neurobiology, & Anatomy, COphthalmology and Cell Biology, Neurobiology, & Anatomy, 1Medical College of Wisconsin, Milwaukee, Wisconsin
2Neonatal Intensive Care Unit, Children’s Hospital of Wisconsin, Milwaukee, Wisconsin

Commercial Relationships: C. Devika Subramaniam, None; Adam M. Dubis, None; Pooja Godara, None; Debra Felzer, None; Cathy Brault, None; Joseph Carroll, None; Deborah Costakos, None

Support: NIH grants EY017607, EY001931, EY014537. RD and Linda Peters Foundation. Research to Prevent Blindness.


Purpose:To evaluate subclinical macular findings in premature patients at risk of retinopathy of prematurity (ROP) with the use of handheld spectral domain-optical coherence tomography (SD-OCT).

Methods:Thirty-five patients ages 30 weeks gestation to 57 weeks gestation were imaged using Bioptigen Hand Held Probe SD-OCT (HHP-SDOCT) (Bioptigen, Research Triangle Park, NC, USA). Images were acquired in non-sedated infants in the neonatal intensive care unit or outpatient clinic during ROP screening examinations. Informed consent was obtained and all research was approved by the local institutional review board. Some subjects were followed and re-imaged over the course of several weeks. One hundred ninety-six total images were acquired, and one eye from each patient was evaluated for cystoid macular edema (CME) and persistence of inner retinal layers.

Results:One hundred eighteen (60.2%) of the images were usable (defined as having scans passing through the fovea with clearly identifiable retinal layers). CME was seen in 5 of 17 eyes (29.4%) with stage 0 ROP, 0 of 2 eyes (0%) with stage 1 ROP, 1 of 5 eyes (20%) with stage 2 ROP, and 0 of 3 eyes (0%) with stage 3 ROP. Persistence of inner retinal layers was seen in 17 of 17 eyes (100%) with stage 0 ROP, 2 of 2 eyes (100%) with stage 1 ROP, 4 of 5 eyes (80%) with stage 2 ROP, and 3 of 3 eyes (100%) with stage 3 ROP.

Conclusions:Consistent with previous reports (Vinekar A, et al. IOVS 2011;52:5183-5188; Maldonado RS, et al. Ophthalmology 2011;118:2315-2325), subclinical CME is seen in premature infants; however, CME does not appear to be correlated with ROP stage. This suggests that there may be other etiologies for the CME seen in this patient population. Our data suggests there is persistence of inner retinal layers in premature infants, regardless of ROP stage. Hand-held SD-OCT imaging is a viable technique for evaluating subclinical macular findings in premature infants, though much larger datasets are needed from multiple centers to develop a better understanding of what is "normal" and what truly represents subclinical pathology.

Keywords: retinopathy of prematurity • imaging/image analysis: clinical • development

© 2012, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.